These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26126960)

  • 1. ALG3-CDG: Report of two siblings with antenatal features carrying homozygous p.Gly96Arg mutation.
    Lepais L; Cheillan D; Frachon SC; Hays S; Matthijs G; Panagiotakaki E; Abel C; Edery P; Rossi M
    Am J Med Genet A; 2015 Nov; 167A(11):2748-54. PubMed ID: 26126960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
    Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
    Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal glycosylation defect due to ALG3 and COG5 variants detected via amniocentesis: Complex glycosylation defect with embryonic lethal phenotype.
    Ferrer A; Starosta RT; Ranatunga W; Ungar D; Kozicz T; Klee E; Rust LM; Wick M; Morava E
    Mol Genet Metab; 2020 Dec; 131(4):424-429. PubMed ID: 33187827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.
    Farolfi M; Cechova A; Ondruskova N; Zidkova J; Kousal B; Hansikova H; Honzik T; Liskova P
    BMC Ophthalmol; 2021 Jun; 21(1):249. PubMed ID: 34090370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel variants and clinical symptoms in four new ALG3-CDG patients, review of the literature, and identification of AAGRP-ALG3 as a novel ALG3 variant with alanine and glycine-rich N-terminus.
    Himmelreich N; Dimitrov B; Geiger V; Zielonka M; Hutter AM; Beedgen L; Hüllen A; Breuer M; Peters V; Thiemann KC; Hoffmann GF; Sinning I; Dupré T; Vuillaumier-Barrot S; Barrey C; Denecke J; Kölfen W; Düker G; Ganschow R; Lentze MJ; Moore S; Seta N; Ziegler A; Thiel C
    Hum Mutat; 2019 Jul; 40(7):938-951. PubMed ID: 31067009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
    Alsharhan H; Ng BG; Daniel EJP; Friedman J; Pivnick EK; Al-Hashem A; Faqeih EA; Liu P; Engelhardt NM; Keller KN; Chen J; Mazzeo PA; ; Rosenfeld JA; Bamshad MJ; Nickerson DA; Raymond KM; Freeze HH; He M; Edmondson AC; Lam C
    J Inherit Metab Dis; 2021 Jul; 44(4):987-1000. PubMed ID: 33583022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALG3-CDG: lethal phenotype and novel variants in Chinese siblings.
    Bian Y; Qiao C; Zheng S; Qiu H; Li H; Zhang Z; Yin S; Jiang H; Li-Ling J; Liu C; Lyu Y
    J Hum Genet; 2020 Dec; 65(12):1129-1134. PubMed ID: 32655146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.
    Paketci C; Edem P; Hiz S; Sonmezler E; Soydemir D; Sarikaya Uzan G; Oktay Y; O'Heir E; Beltran S; Laurie S; Töpf A; Lochmuller H; Horvath R; Yis U
    Brain Dev; 2020 Aug; 42(7):539-545. PubMed ID: 32389449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
    Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
    Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
    Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorders of glycosylation: The Saudi experience.
    Alsubhi S; Alhashem A; Faqeih E; Alfadhel M; Alfaifi A; Altuwaijri W; Alsahli S; Aldhalaan H; Alkuraya FS; Hundallah K; Mahmoud A; Alasmari A; Mutairi FA; Abduraouf H; AlRasheed L; Alshahwan S; Tabarki B
    Am J Med Genet A; 2017 Oct; 173(10):2614-2621. PubMed ID: 28742265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.
    Kane MS; Davids M; Adams C; Wolfe LA; Cheung HW; Gropman A; Huang Y; ; Ng BG; Freeze HH; Adams DR; Gahl WA; Boerkoel CF
    Am J Hum Genet; 2016 Feb; 98(2):339-46. PubMed ID: 26805780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COG6-CDG: Expanding the phenotype with emphasis on glycosylation defects involved in the causation of male disorders of sex development.
    Mandel H; Cohen Kfir N; Fedida A; Shuster Biton E; Odeh M; Kalfon L; Ben-Harouch S; Fleischer Sheffer V; Hoffman Y; Goldberg Y; Dinwiddie A; Dumin E; Eran A; Apel-Sarid L; Tiosano D; Falik-Zaccai TC
    Clin Genet; 2020 Oct; 98(4):402-407. PubMed ID: 32683677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
    Fernlund E; Andersson O; Ellegård R; Årstrand HK; Green H; Olsson H; Gunnarsson C
    Forensic Sci Int Genet; 2019 Nov; 43():102111. PubMed ID: 31563034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDG-Id in two siblings with partially different phenotypes.
    Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
    Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital disorders of glycosylation with emphasis on cerebellar involvement.
    Barone R; Fiumara A; Jaeken J
    Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.
    de Lonlay P; Seta N; Barrot S; Chabrol B; Drouin V; Gabriel BM; Journel H; Kretz M; Laurent J; Le Merrer M; Leroy A; Pedespan D; Sarda P; Villeneuve N; Schmitz J; van Schaftingen E; Matthijs G; Jaeken J; Korner C; Munnich A; Saudubray JM; Cormier-Daire V
    J Med Genet; 2001 Jan; 38(1):14-9. PubMed ID: 11134235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.